SEC 13F Intelligence

Managers / Q3 2019 · view latest →

Mohican Financial Management, LLC

CIK 0001367663 · 21 RIVER RD, SUITE 2100, WILTON, CT, 06897 · 203-423-8029

Reported Value
$65M
Q3 2019
Positions
46
Filings on Record
11
2019–present window
Filed
Oct 25, 2019
original filing

Summary

Mohican Financial Management, LLC reported $65M in U.S.-listed holdings across 46 positions for Q3 2019.

Its largest position, Q2, represents 5.7% of the portfolio.

Compared with Q2 2019, the fund opened 5 new positions and exited 8.

Portfolio Metrics

Turnover
+20.1%
vs prior filed quarter
Top-10 Concentration
+39.2%
share of reported value
Largest Position
+5.7%
Q2
New / Exited
5 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $24MQ4 ’18Q1 ’19: $31MQ2 ’19: $68MQ2 ’19Q3 ’19: $65MQ4 ’19: $64MQ4 ’19Q1 ’20: $70MQ2 ’20: $55MQ2 ’20Q3 ’20: $80MQ4 ’20: $98MQ4 ’20Q1 ’21: $154MQ2 ’21: $256MQ2 ’21filingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 97.5%YANKEE: 2.5%
  • US DOMESTIC · 97.5% · $63M
  • YANKEE · 2.5% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MERCADOLIBRE INCNEW+1.50M1.50M+$2M$2M
FTI CONSULTING INCNEW+1.50M1.50M+$2M$2M
NXP SEMICONDUCTORS N VNEW+1.50M1.50M+$2M$2M
VISHAY INTERTECHNOLOGY INCNEW+1.50M1.50M+$1M$1M
MESA LABS INCNEW+700.0K700.0K+$748,000$748,000
FIREEYE INCADDED+1.00M1.25M+$933,000$1M
LIVE NATION ENTERTAINMENT INADDED+1.00M1.46M+$1M$2M
CYPRESS SEMICONDUCTOR CORPSOLD OUT−1.00M0−$2M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

43 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1Q2 HLDGS INCNOTE 0.750% 2/15.66%$4M2.50M
2AEROJET ROCKETDYNE HLDGS INCNOTE 2.250%12/14.61%$3M1.50M
3FIVE9 INCNOTE 0.125% 5/04.45%$3M2.00M
4INSULET CORPNOTE 1.375%11/14.28%$3M1.51M
5CHEGG INCNOTE 0.250% 5/13.95%$3M2.00M
6MERCADOLIBRE INCNOTE 2.000% 8/13.41%$2M1.50M
7ENVESTNET INCNOTE 1.750% 6/03.33%$2M2.00M
8FIREEYE INCNOTE 0.875% 6/0 · NOTE 1.625% 6/03.26%$2M2.25M
9KAMAN CORPNOTE 3.250% 5/03.25%$2M1.86M
10VOCERA COMMUNICATIONS INCNOTE 1.500% 5/13.22%$2M2.00M
11TTM TECHNOLOGIES INCNOTE 1.750%12/13.07%$2M1.50M
12SILICON LABORATORIES INCNOTE 1.375% 3/03.01%$2M1.50M
13FTI CONSULTING INCNOTE 2.000% 8/12.82%$2M1.50M
14HELIX ENERGY SOLUTIONS GRP INOTE 4.125% 9/12.70%$2M1.50M
15INFINERA CORPORATIONNOTE 2.125% 9/02.68%$2M2.00M
16GUIDEWIRE SOFTWARE INCNOTE 1.250% 3/12.64%$2M1.50M
17LIVE NATION ENTERTAINMENT INNOTE 2.500% 3/12.63%$2M1.46M
18TWITTER INCNOTE 0.250% 6/1 · NOTE 1.000% 9/12.62%$2M1.65M
19NEWPARK RES INCNOTE 4.000%12/02.55%$2M1.50M
20NXP SEMICONDUCTORS N VNOTE 1.000%12/02.51%$2M1.50M
21ENCORE CAP GROUP INCNOTE 2.875% 3/1 · NOTE 3.000% 7/02.34%$2M1.56M
22EXACT SCIENCES CORPNOTE 1.000% 1/12.32%$2M1.06M
23PACIRA BIOSCIENCESNOTE 2.375% 4/02.29%$1M1.50M
24VISHAY INTERTECHNOLOGY INCNOTE 2.250% 6/12.16%$1M1.50M
25KNOWLES CORPNOTE 3.250%11/01.97%$1M1.00M
26PROS HOLDINGS INCNOTE 2.000% 6/01.95%$1M1.00M
27INSMED INCNOTE 1.750% 1/11.93%$1M1.50M
28RETROPHIN INCNOTE 2.500% 9/11.84%$1M1.60M
29II VI INCNOTE 0.250% 9/01.82%$1M1.14M
30GANNETT CO INCNOTE 4.750% 4/11.66%$1M1.00M
31CARBONITE INCNOTE 2.500% 4/01.46%$947,0001.00M
32QUOTIENT TECHNOLOGY INCNOTE 1.750%12/01.46%$947,0001.02M
33EZCORP INCNOTE 2.875% 7/01.44%$937,0001.00M
34DEXCOM INCNOTE 0.750% 5/11.28%$834,000525.0K
35ALTAIR ENGR INCNOTE 0.250% 6/01.16%$755,000750.0K
36MESA LABS INCNOTE 1.375% 8/11.15%$748,000700.0K
37SILVER STD RES INCNOTE 2.875% 2/00.99%$646,000639.0K
38FLEXION THERAPEUTICS INCNOTE 3.375% 5/00.87%$564,000625.0K
39VEECO INSTRS INC DELNOTE 2.700% 1/10.82%$531,000595.0K
40TEAM INCNOTE 5.000% 8/00.80%$517,000467.0K
41THERAVANCE BIOPHARMA INCNOTE 3.250%11/00.72%$465,000500.0K
42TIMKENSTEEL CORPNOTE 6.000% 6/00.61%$394,000425.0K
43GLOBAL EAGLE ENTMT INCNOTE 2.750% 2/10.33%$215,000500.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2021$256M70Jul 28, 202113F-HRchanges · EDGAR ↗
Q1 2021$154M51Apr 29, 202113F-HRchanges · EDGAR ↗
Q4 2020$98M46Jan 14, 202113F-HRchanges · EDGAR ↗
Q3 2020$80M47Oct 20, 202013F-HRchanges · EDGAR ↗
Q2 2020$55M40Jul 20, 202013F-HRchanges · EDGAR ↗
Q1 2020$70M47Apr 29, 202013F-HRchanges · EDGAR ↗
Q4 2019$64M40Jan 28, 202013F-HRchanges · EDGAR ↗
Q3 2019$65M46Oct 25, 201913F-HRchanges · EDGAR ↗
Q2 2019$68M49Jul 11, 201913F-HRchanges · EDGAR ↗
Q1 2019$31M31Apr 23, 201913F-HRchanges · EDGAR ↗
Q4 2018$24M30Jan 29, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.